Credit Suisse analyst Amanda Foo upgraded Raffles Medical Group to Outperform from Neutral with a price target of S$1.80, up from S$1.30. The analyst lifted estimates to reflect the company’s ability to sustain earnings post-pandemic.
Published first on TheFly